Products for Research Use Only
RegisterLogin

XmAb-2513

CAT: 0804-HY-P991638Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991638Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
XmAb-2513 is a humanized monoclonal antibody inhibitor targeting CD30. XmAb-2513 has significant anti-proliferative activity and superior antibody-dependent cell-mediated cytotoxicity (ADCC) as well as antibody-dependent cell-mediated phagocytosis (ADCP) . XmAb-2513 can be used for hematologic malignancies like Hodgkin Lymphoma (HL) and Anaplastic Large Cell Lymphoma (ALCL) research[1].
UNSPSC
12352100
Target
TNF Receptor
Related Pathways
Apoptosis
Field of Research
Cancer
References & Citations
[1]Lawrence C E, et al. XmAb™ 2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies[J]. 2007.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF8/CD30

Related Products

CatalogName
HY-P99381-01XmAb 5592
HY-P991252-01XmAb-7195
HY-P991438XmAb-662
HY-125930T-2513
HY-125930AT-2513 (hydrochloride)
HY-111418-01EBI-2511
HY-108557-01TCS 2510
HY-19727A-01FOY 251
HY-117737A-01RRD-251
HY-117996-01KPT-251

Alternative Products

CatalogName
T9901A-1897-01XmAb-2513
PTX25594Anti-Human CD30/TNFRSF8 (XmAb 2513)
MBS1581298-01Research Grade Anti-Human CD30/TNFRSF8 (XmAb 2513)
A135852Anti-CD30/TNFRSF8 (XmAb 2513) Biosimilar (Monoclonal, IgG)
T40365T-2513
MBS5780739CVT-2513
MBS5822416XmAb 5592
MBS5805900T-2513 hydrochloride
T9901A-1668-01XmAb-662
T9901A-1575-01XmAb-7195

Popular Products